Dr. Frédéric Triebel Presenting at the World Immunotherapy Congress 2017 – Nasdaq
|
Dr. Frédéric Triebel Presenting at the World Immunotherapy Congress 2017
Nasdaq SYDNEY, Australia, Oct. 19, 2017 (GLOBE NEWSWIRE) — Prima BioMed Ltd (ASX:PRR) (NASDAQ:PBMD) (“Prima”) announces that Dr. Frédéric Triebel, Prima’s Chief Scientific Officer & Medical Officer, will be giving an oral presentation on Prima’s ongoing … |
|
Dr. Frédéric Triebel Presenting at the World Immunotherapy Congress 2017
Nasdaq SYDNEY, Australia, Oct. 19, 2017 (GLOBE NEWSWIRE) — Prima BioMed Ltd (ASX:PRR) (NASDAQ:PBMD) (“Prima”) announces that Dr. Frédéric Triebel, Prima’s Chief Scientific Officer & Medical Officer, will be giving an oral presentation on Prima’s ongoing … |
AGDAILY |
CRISPR Gene Editing Aims to Improve ‘Orphan Crops’ | Agweb.com
AgWeb Nigel Taylor, interim director of the Donald Danforth Plant Science Center in Missouri, speaks about using CRISPR to make cassava more disease resistant. Pioneer to bring CRISPR-Cas technology to Danforth Center …AGDAILY |
AGDAILY |
CRISPR Gene Editing Aims to Improve ‘Orphan Crops’ | Agweb.com
AgWeb Nigel Taylor, interim director of the Donald Danforth Plant Science Center in Missouri, speaks about using CRISPR to make cassava more disease resistant. Pioneer to bring CRISPR-Cas technology to Danforth Center …AGDAILY |
Varsity Online |
Engineering meets life sciences in synthetic biology
Varsity Online Manipulation of model organisms is a dream for many a scientist and synthetic biology has shown great advances in achieving this in the past two decades. Alex van der Wateren recounts some of the field’s achievements and explains how synthetic … |